European Heart Journal最新文献

筛选
英文 中文
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study. 人工智能增强心电图预测反流性瓣膜性心脏病:一项国际研究
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-16 DOI: 10.1093/eurheartj/ehaf448
Yixiu Liang,Arunashis Sau,Boroumand Zeidaabadi,Joseph Barker,Konstantinos Patlatzoglou,Libor Pastika,Ewa Sieliwonczyk,Zachary Whinnett,Nicholas S Peters,Ziqing Yu,Xi Liu,Shuo Wang,Hongyang Lu,Daniel B Kramer,Jonathan W Waks,Yangang Su,Junbo Ge,Fu Siong Ng
{"title":"Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study.","authors":"Yixiu Liang,Arunashis Sau,Boroumand Zeidaabadi,Joseph Barker,Konstantinos Patlatzoglou,Libor Pastika,Ewa Sieliwonczyk,Zachary Whinnett,Nicholas S Peters,Ziqing Yu,Xi Liu,Shuo Wang,Hongyang Lu,Daniel B Kramer,Jonathan W Waks,Yangang Su,Junbo Ge,Fu Siong Ng","doi":"10.1093/eurheartj/ehaf448","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf448","url":null,"abstract":"BACKGROUND AND AIMSValvular heart disease (VHD) is a significant source of morbidity and mortality, though early intervention can improve outcomes. This study aims to develop artificial intelligence-enhanced electrocardiography (AI-ECG) models to diagnose and predict future moderate or severe regurgitant VHDs (rVHDs), including mitral regurgitation (MR), tricuspid regurgitation (TR), and aortic regurgitation (AR).METHODSThe AI-ECG models were developed in a data set of 988 618 ECG and transthoracic echocardiogram pairs from 400 882 patients from Zhongshan Hospital, Shanghai, China. The AI-ECG models used a residual convolutional neural network with a discrete-time survival loss function. External evaluation was performed in outpatients from a secondary care data set from Beth Israel Deaconess Medical Center, Boston, USA, consisting of 34 214 patients with linked echocardiography.RESULTSIn the internal test set, the AI-ECG models accurately predicted future significant MR [C-index 0.774, 95% confidence interval (CI) 0.753-0.792], AR (0.691, 95% CI 0.657-0.720), and TR (0.793, 95% CI 0.777-0.808). In age- and sex-adjusted Cox models, the highest risk quartile had a hazard ratio (HR) of 7.6 (95% CI 5.8-9.9, P < .0001) for risk of future significant MR, compared with the lowest risk quartile. For future AR and TR, the equivalent HRs were 3.8 (95% CI 2.7-5.5) and 9.9 (95% CI 7.5-13.0), respectively. These findings were confirmed in the transnational external test set. Imaging association analyses demonstrated AI-ECG predictions were associated with subclinical chamber remodelling.CONCLUSIONSThis study developed AI-ECG models to diagnose and predict rVHDs and validated the models in a transnational and ethnically distinct cohort. The AI-ECG models could be utilized to guide surveillance echocardiography in patients at risk of future rVHDs, to facilitate early detection and intervention.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"12 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144645883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rheumatic valve disease and acceleration of cardiac aging in Africa: next-generation answers for an old, orphan problem. 非洲风湿性瓣膜疾病和心脏老化加速:新一代老年孤儿问题的答案。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-16 DOI: 10.1093/eurheartj/ehaf350
Maurizio Pesce,Pasquale Maffia,Bamba Gaye
{"title":"Rheumatic valve disease and acceleration of cardiac aging in Africa: next-generation answers for an old, orphan problem.","authors":"Maurizio Pesce,Pasquale Maffia,Bamba Gaye","doi":"10.1093/eurheartj/ehaf350","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf350","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"108 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144639954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circadian rhythms in cardiovascular disease. 心血管疾病的昼夜节律。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-15 DOI: 10.1093/eurheartj/ehaf367
Ilse R Kelters, Yvonne Koop, Martin E Young, Andreas Daiber, Linda W van Laake
{"title":"Circadian rhythms in cardiovascular disease.","authors":"Ilse R Kelters, Yvonne Koop, Martin E Young, Andreas Daiber, Linda W van Laake","doi":"10.1093/eurheartj/ehaf367","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf367","url":null,"abstract":"<p><p>Circadian rhythms, controlled by the suprachiasmatic nucleus and peripheral clocks, regulate 24-h cycles in biological processes such as the cardiovascular system. Circadian rhythms influence autonomic balance, with parasympathetic dominance during sleep supporting cardiac recovery and sympathetic activation during the day supporting circulatory demand. Congruent with systemic and cellular circadian rhythmicity, 24-h patterns arise in the pathophysiology of cardiovascular diseases, including ischaemic heart disease, heart failure, and arrhythmias. Daily variations influence the timing and outcome of myocardial infarction, with studies reporting patterns in infarct size depending on the time of onset. Similar daily patterns are observed in cardio- and cerebrovascular complications. In heart failure, circadian rhythms are dampened but remain intact, suggesting the potential for incorporating timing in diagnostics and therapies. Sudden cardiac death follows a distinct pattern, with a higher incidence in the morning. Atrial fibrillation onset, on the other hand, occurs more frequently at night. Risk factors and modifiers, such as physiological, psychological, lifestyle, and environmental factors and comorbidities interact with circadian rhythms, thereby impacting cellular pathomechanisms and development of cardiovascular health and disease. Chronotherapy, which aligns treatments with circadian rhythms, has demonstrated potential for improving the efficacy of cardiovascular therapies. This review examines the influence of circadian rhythms on cardiovascular health in the context of specific cardiac diseases and risk factors, and it highlights the therapeutic opportunities informed by circadian patterns.</p>","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":""},"PeriodicalIF":37.6,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144636596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac magnetic resonance in sarcoidosis-associated arrhythmia prediction: beyond current guidelines. 心脏磁共振在结节病相关心律失常预测中的应用:超越现行指南。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-15 DOI: 10.1093/eurheartj/ehaf442
Ana Pericao,Vasileios Kouranos,Rakesh Sharma
{"title":"Cardiac magnetic resonance in sarcoidosis-associated arrhythmia prediction: beyond current guidelines.","authors":"Ana Pericao,Vasileios Kouranos,Rakesh Sharma","doi":"10.1093/eurheartj/ehaf442","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf442","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"15 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144630257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectives. 人工智能在心血管药物治疗中的应用与展望。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-15 DOI: 10.1093/eurheartj/ehaf474
Francesco Costa,Juan Jose Gomez Doblas,Arancha Díaz Expósito,Marianna Adamo,Fabrizio D'Ascenzo,Lukasz Kołtowski,Luca Saba,Guiomar Mendieta,Felice Gragnano,Paolo Calabrò,Lina Badimon,Borja Ibañez,Roxana Mehran,Dominick J Angiolillo,Thomas Lüscher,Davide Capodanno
{"title":"Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectives.","authors":"Francesco Costa,Juan Jose Gomez Doblas,Arancha Díaz Expósito,Marianna Adamo,Fabrizio D'Ascenzo,Lukasz Kołtowski,Luca Saba,Guiomar Mendieta,Felice Gragnano,Paolo Calabrò,Lina Badimon,Borja Ibañez,Roxana Mehran,Dominick J Angiolillo,Thomas Lüscher,Davide Capodanno","doi":"10.1093/eurheartj/ehaf474","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf474","url":null,"abstract":"Recent advances in artificial intelligence (AI) have shown great potential in improving cardiovascular pharmacotherapy by optimizing drug selection, predicting therapeutic efficacy and adverse effects, ultimately improving patient outcomes. Leveraging techniques like machine learning and in silico modelling, AI can identify populations likely to benefit from specific treatments, expedite novel drug discovery and reduce costs. Computational methods can also facilitate the detection of drug interactions and tailor interventions based on real-world data, supporting personalized care. Artificial intelligence-based approaches also show promise in streamlining clinical trial design and execution, leveraging on real-time data on patient responsiveness, enhancing recruitment efficiency. However, in order to fully realize these benefits, robust validation across diverse patient populations is necessary to ensure accuracy and generalizability. In addition, addressing concerns regarding data quality, privacy, and bias is equally critical to avoid exacerbating existing healthcare disparities. Scientific societies and regulatory agencies must ultimately establish standardized frameworks for data management, model certification, and transparency, to enable safe and effective integration of AI into clinical practice. This manuscript aims at systematically reviewing the current state-of-the-art applications of AI in cardiovascular pharmacotherapy, describing their current potential in guiding treatment decisions, refine trial methodologies and support drug discovery.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"94 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144630360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left atrial appendage closure: a reappraisal of atrial fibrillation guidelines. 左心房附件关闭:心房颤动指南的重新评估。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-15 DOI: 10.1093/eurheartj/ehaf454
Jens Erik Nielsen-Kudsk,Lucas V A Boersma,A John Camm
{"title":"Left atrial appendage closure: a reappraisal of atrial fibrillation guidelines.","authors":"Jens Erik Nielsen-Kudsk,Lucas V A Boersma,A John Camm","doi":"10.1093/eurheartj/ehaf454","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf454","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"29 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144630255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Illicit stimulants and sudden cardiac death: fatal attraction and sex interaction. 非法兴奋剂和心脏性猝死:致命的吸引力和性互动。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-15 DOI: 10.1093/eurheartj/ehaf443
Orianne Weizman,Eloi Marijon
{"title":"Illicit stimulants and sudden cardiac death: fatal attraction and sex interaction.","authors":"Orianne Weizman,Eloi Marijon","doi":"10.1093/eurheartj/ehaf443","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf443","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"84 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144630359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hot topics in prevention: resistant hypertension, blood pressure variability, triglycerides, and apoB-containing lipoproteins. 预防的热门话题:顽固性高血压、血压变异性、甘油三酯和载脂蛋白。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf444
Filippo Crea
{"title":"Hot topics in prevention: resistant hypertension, blood pressure variability, triglycerides, and apoB-containing lipoproteins.","authors":"Filippo Crea","doi":"10.1093/eurheartj/ehaf444","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf444","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"5 1","pages":"2607-2610"},"PeriodicalIF":39.3,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144622139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of large areas of thin-cap fibroatheroma in a recurrent STEMI patient using a novel artificial intelligence algorithm: moving from 2D to 3D. 使用一种新的人工智能算法检测复发性STEMI患者的大面积薄帽纤维粥样瘤:从2D移动到3D。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf189
Thijs J Luttikholt, Jos Thannhauser, Niels van Royen
{"title":"Detection of large areas of thin-cap fibroatheroma in a recurrent STEMI patient using a novel artificial intelligence algorithm: moving from 2D to 3D.","authors":"Thijs J Luttikholt, Jos Thannhauser, Niels van Royen","doi":"10.1093/eurheartj/ehaf189","DOIUrl":"10.1093/eurheartj/ehaf189","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2712"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12257293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral health benefits and safety of xylitol and potential cardiovascular risk: questioning the validity of the model of Witkowski et al. 木糖醇的口腔健康益处和安全性以及潜在的心血管风险:质疑Witkowski等人模型的有效性。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf058
Gregory C Valentine, Eva Söderling, Peter Milgrom
{"title":"Oral health benefits and safety of xylitol and potential cardiovascular risk: questioning the validity of the model of Witkowski et al.","authors":"Gregory C Valentine, Eva Söderling, Peter Milgrom","doi":"10.1093/eurheartj/ehaf058","DOIUrl":"10.1093/eurheartj/ehaf058","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2705-2706"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12257477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143603822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信